West syndrome: Aetiology, therapeutic options, clinical course and prognostic factors;Síndrome de West: Etiología, opciones terapéuticas, evolución clínica y factores pronósticos

Revista de Neurologia

Volumn 52, Issue 2, 2011, Pages 81-89

  Arce Portillo, Elena ^a   Rufo Campos, Miguel ^a   Muñoz Cabello, Beatriz ^a   Blanco Martínez, Bárbara ^a   Madruga Garrido, Marcos ^a   Ruiz Del Portal, Luis ^a   Fernández Mensaque, Ramón Candau ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

ACTH; Aetiology; Infantile spasms; Prognostic factors; Side effects; Vigabatrine; West syndrome

Indexed keywords

CORTICOTROPIN; VIGABATRIN; ANTICONVULSIVE AGENT;

ARTICLE; DISEASE COURSE; EPILEPSY; HUMAN; HYPOXIA; ISCHEMIA; MAJOR CLINICAL STUDY; PROGNOSIS; TREATMENT RESPONSE; WEST SYNDROME; BRAIN ISCHEMIA; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAPHY; FEMALE; INFANT; INFANTILE SPASM; MALE; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SPASMS, INFANTILE; TREATMENT OUTCOME; VIGABATRIN;

EID: 79952225168     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5202.2010392     Document Type: Article

References (30)

1. Herranz JL, Argumosa A. Propuestas para el tratamiento de los niños con síndrome de West. Rev Neurol 2000; 31: 578-83.
2. Casas C. Síndrome de West. In: Epilepsia. 1 ed. Madrid: Ergón; 2002. p. 355-69.
3. Galicchio S, Cersósimo R, Caraballo R, Yépez I, Medina C, Fejerman N. Resonancia magnética cerebral en el estudio del síndrome de West. Rev Neurol 1999; 28: 685-7. (Pubitemid 29232755)
4. Hamano S, Yoshinari S, Higurashi N, Tanaka M, Minamitani M, Eto Y. Developmental outcomes of cryptogenic West syndrome. J Pediatr 2007; 150: 295-9. (Pubitemid 46328965)
5. Golomb MR, Garg BP, Williams LS. Outcomes of children with infantile spasms after perinatal stroke. Pediatr Neurol 2006; 34: 291-5. (Pubitemid 44399744)
6. Riikonen R. Favourable prognostic factors with infantile spasms. Eur J Paediatric Neurol 2010; 14: 13-8.
7. Hrachovy R, Frost J. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J Clin Neurophysiol 2003; 20: 408-25. (Pubitemid 38133969)
8. Matsumoto A, Watanabe K, Negoro T, Sugiura M, Iwase K, Hara K, et al. Infantile spasms: etiological factors, clinical aspects, and long term prognosis in 200 cases. Eur J Pediatr 1981; 135: 239-44. (Pubitemid 11137447)
9. Riikonen R. A long term follow study of 214 children with the syndrome of infantile spasms. Neuropediatrics 1982; 13: 14-23. (Pubitemid 12192677)
10. Ohtahara S, Ohtsuka Y, Yamatogi Y, Oka E, Yoshinaga H, Sato M. Prenatal etiologies of West syndrome. Epilepsia 1993; 34: 716-22. (Pubitemid 23228137)
11. Campistol J, García-Cazorla A. Síndrome de West. Análisis, factores etiológicos y opciones terapéuticas. Rev Neurol 2003; 37: 345-52. (Pubitemid 37248232)
12. Casas C, Alarcón H, Domingo MR. Semiología clínica de las displasias corticales en la infancia. En Rufo-Campos M, ed. Las crisis epilépticas en los desórdenes del desarrollo cortical. Madrid: Momento Médico Iberoamericana; 2010. p. 37-79.
13. Rufo M, Santiago C, Castro E. Uso de monoterapia con vigabatrina en el tratamiento del síndrome de West. Rev Neurol 1997; 25: 1365-8.
14. Rufo M, Casas C, Herranz JL, Arce E; Grupo de estudio de epilepsia de la SEN. Actitud terapéutica en el síndrome de West. In: Guías clinicoterapéuticas en epilepsia. Barcelona: Prous Science; 2008. p. 209-17.
15. Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD. Vigabatrin: 2008 update. Epilepsia 2009; 50: 163-73.
16. Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: expert opinion 2005. J Child Neurol 2005; 20 (Suppl 1): S1-56.
17. Lux A, Edwards S, Hancock E. The United Kingdom infantile spasms study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004; 364: 1773-8. (Pubitemid 39488062)
18. Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, et al. Practice parameter: medical treatment of infantile spasms. Report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004; 62: 1668-81.
19. Ito M, Aiba H, Hashimoto K, Kuroki S, Tomiwa K, Okuno T, et al. Low-dose ACTH therapy for West syndrome. Initial effects and long term outcome. Neurology 2002; 58: 110-4.
20. Hattori A, Hayano J, Fujimoto S. Cardiac vagal activation by adrenocortocotropic hormona treatment in infants with West syndrome. Tohoku J Exp Med 2007; 211: 133-9.
21. Hamano S, Yamashita S, Tanaka M, Yoshinari S, Minamitani M, Eto Y. Therapeutic efficacy and adverse effects of adrenocorticotropic hormone therapy in West syndrome: differences in dosage of adrenocorticotropic hormone, onset of age, and cause. J Pediatr 2006; 148: 485-8.
22. Kondo Y, Okumura A, Watanabe K, Negoro T, Kato T, Kubota T, et al. Comparison of two low dose ACTH therapies for West syndrome: their efficacy and side effect. Brain Dev 2005; 27: 326-30. (Pubitemid 40991751)
23. Lotze TE, Wilfong AA. Zonisamida treatment for symptomatic infantile spasms. Neurology 2004; 62: 296-8. (Pubitemid 38167144)
24. Hosain SA, Merchant S, Solomon GE, Chutorian A. Topiramate for the treatment of infantile spasms. J Child Neurol 2006; 21: 17-9. (Pubitemid 43778759)
25. Kossoff EH, Hartman AL, Rubenstein JE, Vining E. High dose oral prednisolone for infantile spasms: an effective and less expensive alternative to ACTH. Epilepsy Behav 2009; 14: 674-6.
26. Mytinger JR, Quigg M, Taft WC, Buck ML, Rust RS. Outcomes in treatment of infantile spasms with pulse methylprednisolone. J Child Neurol 2010; 25: 948-53.
27. Haberlandt E, Weger C, Sigl SB, Rauchenzauner M, Scholl-Bürgi S, Rostásy K, et al. Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes. Pediatr Neurol 2010; 42: 21-7.
28. Zou LP, Wang X, Dong CH, Chen CH, Zhao W, Zhao RY. Three week combination treatment with ACTH+ magnesium sulphate versus ACTH monotherapy for infantile spasms: a 24 week, randomized, open label, follow up study in China. Clin Ther 2010; 32: 692-700.
29. Durá-Travé T, Yoldi-Petri ME, Hualde-Olascoaga J, Etayo-Etayo V. Epilepsias y síndromes epilépticos durante el primer año de vida. Rev Neurol 2009; 48: 281-4.
30. Rener-Primec Z, Stare J, Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia 2006; 47: 2202-5. (Pubitemid 44952280)